Staphysagria (Energique, Inc.)
Welcome to the PulseAid listing for the Staphysagria drug offered from Energique, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Energique, Inc. |
NON-PROPRIETARY NAME: | Staphysagria |
SUBSTANCE NAME: | DELPHINIUM STAPHISAGRIA SEED |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2016-08-23 |
END MARKETING DATE: | 0000-00-00 |
Staphysagria HUMAN OTC DRUG Details:
Item Description | Staphysagria from Energique, Inc. |
LABELER NAME: | Energique, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200([hp_C]/mL) |
START MARKETING DATE: | 2016-08-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 44911-0392_97e86194-53ee-47ba-b002-e3c73d7b5da9 |
PRODUCT NDC: | 44911-0392 |
APPLICATION NUMBER: | |
Other DELPHINIUM STAPHISAGRIA SEED Pharmaceutical Manufacturers / Labelers: